RA Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17M | Hold |
1,150,000
| – | – | 0.29% | 39 |
|
|
2025
Q1 | $20.6M | Hold |
1,150,000
| – | – | 0.34% | 41 |
|
|
2024
Q4 | $20M | Buy |
+1,150,000
| New | +$20M | 0.27% | 56 |
|
|
2023
Q1 | – | Sell |
-3,984,681
| Closed | -$83.8M | – | 69 |
|
|
2022
Q4 | $83.8M | Sell |
3,984,681
-938,260
| -19% | -$19.7M | 1.7% | 22 |
|
|
2022
Q3 | $121M | Hold |
4,922,941
| – | – | 2.59% | 8 |
|
|
2022
Q2 | $119M | Hold |
4,922,941
| – | – | 3.18% | 6 |
|
|
2022
Q1 | $127M | Sell |
4,922,941
-691,487
| -12% | -$17.8M | 2.77% | 6 |
|
|
2021
Q4 | $174M | Hold |
5,614,428
| – | – | 3.07% | 4 |
|
|
2021
Q3 | $136M | Hold |
5,614,428
| – | – | 1.89% | 17 |
|
|
2021
Q2 | $81.9M | Hold |
5,614,428
| – | – | 1.31% | 24 |
|
|
2021
Q1 | $140M | Buy |
5,614,428
+1,056,561
| +23% | +$26.4M | 2.11% | 12 |
|
|
2020
Q4 | $124M | Sell |
4,557,867
-77,820
| -2% | -$2.12M | 1.74% | 15 |
|
|
2020
Q3 | $85.6M | Hold |
4,635,687
| – | – | 1.57% | 21 |
|
|
2020
Q2 | $94.6M | Buy |
4,635,687
+469,234
| +11% | +$9.58M | 1.84% | 21 |
|
|
2020
Q1 | $60.8M | Sell |
4,166,453
-86,000
| -2% | -$1.25M | 1.92% | 20 |
|
|
2019
Q4 | $60.4M | Buy |
4,252,453
+264,893
| +7% | +$3.76M | 1.83% | 16 |
|
|
2019
Q3 | $46.2M | Buy |
+3,987,560
| New | +$46.2M | 2.75% | 11 |
|